drugset / Trial / NCT01453946

Safety and Maintenance Study of Entocort for Children With Crohn's Disease

NCT01453946 ↗

Phase 3 Completed 55 enrolled Padagis LLC
NaSingle-groupOpen-labelTreatment

Summary

A Safety for Maintenance of Entocort EC for children with mild to moderate Crohn's Disease.

Timeline

Start
2011-12
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 6 mg Oral

Indications